Test ID VITB2 Riboflavin (Vitamin B2), Plasma
Useful For
Evaluation of persons who present the signs of ariboflavinosis
Method Name
Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Reporting Name
Riboflavin (Vitamin B2), PSpecimen Type
Plasma HeparinCollection Container/Tube: Green top (heparin)
Submission Container/Tube: Amber vial (Supply T192)
Specimen Volume: 0.50 mL
Collection Instructions:
1. Fasting-overnight (12-14 hours) (infants-draw prior to next feeding).
2. Send specimen in amber vial to protect from light.
Specimen Minimum Volume
0.25 mL plasma
Specimen Stability Information
Specimen Type | Temperature | Time |
---|---|---|
Plasma Heparin | Frozen (preferred) | 14 days |
Refrigerated | 7 days |
Clinical Information
There are 3 principle vitamin B2-active flavins found in nature-riboflavin, riboflavin 5-phosphate (flavin mononucleotide [FMN]), and riboflavin-5'-adenosyl-diphosphate (flavin adenosine dinucleotide [FAD]). In biological tissues, FMN and FAD serve as prosthetic units for a large variety of flavoproteins, which are hydrogen carriers in oxidation-reduction processes.
Dietary deficiency of riboflavin (ariboflavinosis) is characterized by sore throat, cheilosis (lesions on the lips), angular stomatitis (lesions on the angles of the mouth), glossitis (fissured and magenta-colored tongue), corneal vascularization, dyssebacia (red, scaly, greasy patches on the nose, eyelids, scrotum, and labia), and normocytic, normochromic anemia. Severe riboflavin deficiency may affect the conversion of vitamin B6 to its coenzyme, as well as conversion of tryptophan to niacin.
Riboflavin has a low level of toxicity and no case of riboflavin toxicity in humans has been reported. The limited absorptivity of riboflavin and its ready excretion in the urine normally preclude a health problem due to increased intake of riboflavin.
Reference Values
Normal: 1-19 mcg/L
Cautions
Testing of nonfasting specimens or the use of dietary vitamin B2 supplementation can result in elevated plasma vitamin B2 concentrations.
Day(s) Performed
Tuesday, Thursday
Report Available
2 days (not reported on Saturday or Sunday)Performing Laboratory

Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug Administration.CPT Code Information
84252